Thyrocare Technologies Limited (BOM:539871)
521.95
-0.15 (-0.03%)
At close: Jun 2, 2026
Thyrocare Technologies Revenue
In the fiscal year ending March 31, 2026, Thyrocare Technologies had annual revenue of 8.29B INR with 20.61% growth. Thyrocare Technologies had revenue of 2.24B in the quarter ending March 31, 2026, with 19.66% growth.
Revenue
8.29B
Revenue Growth
+20.61%
P/S Ratio
10.02
Revenue / Employee
4.55M
Employees
1,822
Market Cap
83.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.29B | 1.42B | 20.61% |
| Mar 31, 2025 | 6.87B | 1.15B | 20.19% |
| Mar 31, 2024 | 5.72B | 452.20M | 8.59% |
| Mar 31, 2023 | 5.27B | -621.90M | -10.56% |
| Mar 31, 2022 | 5.89B | 942.40M | 19.05% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| One Global Service Provider | 4.99B |
| Chandan Healthcare | 2.81B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |
| Dr Lalchandani Labs | 43.80M |
Thyrocare Technologies News
- 25 days ago - Thyrocare shares jump over 11% after Q4 results; Net profit surges 117% to Rs 47.1 crore, revenue up 19.7% - Business Upturn
- 2 months ago - Thyrocare Technologies receives Rs 2 crore tax demand notice for FY 2024-25 - Business Upturn
- 4 months ago - Thyrocare Technologies shares fall sharply over 4% today despite strong Q3 FY26 results - Business Upturn
- 8 months ago - Thyrocare shares jump over 11% after strong Q2 results; Approves bonus issue in 2:1 ratio - Business Upturn
- 8 months ago - Thyrocare Technologies Q2 Results: Revenue soars 22% YoY to Rs 216.5 crore, net profit up 79% - Business Upturn
- 11 months ago - Thyrocare shares rally over 7% as Q1 net profit rises 62% YoY Rs 38.06 crore, revenue up 23% YoY - Business Upturn
- 11 months ago - Thyrocare Technologies Q1 Results: Net profit jumps 62% YoY Rs 38.06 crore, revenue up 23% YoY - Business Upturn
- 1 year ago - Thyrocare Technologies Q4 results: Revenue up 21% YoY to Rs 187.2 crore, PAT jumps 88% YoY; Board recommends Rs 21 dividend per share - Business Upturn